(VIANEWS) – SELVAAG BOLIG (SBO.OL), TGS (TGS.OL), NAVAMEDIC (NAVA.OL) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. SELVAAG BOLIG (SBO.OL)
132.6% sales growth and 10.32% return on equity
Selvaag Bolig ASA, a housing development company, engages in the development, construction, and sale of residential properties in Greater Oslo, Bergen, Stavanger, Trondheim, and Stockholm. The company also offers project management services. Selvaag Bolig ASA was incorporated in 2008 and is headquartered in Oslo, Norway. Selvaag Bolig ASA is a subsidiary of Selvaag AS.
Earnings Per Share
As for profitability, SELVAAG BOLIG has a trailing twelve months EPS of kr2.62.
PE Ratio
SELVAAG BOLIG has a trailing twelve months price to earnings ratio of 11.07. Meaning, the purchaser of the share is investing kr11.07 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.32%.
Yearly Top and Bottom Value
SELVAAG BOLIG’s stock is valued at kr29.00 at 07:20 EST, way below its 52-week high of kr39.85 and above its 52-week low of kr28.00.
Growth Estimates Quarters
The company’s growth estimates for the present quarter is a negative 68.2% and positive 316.7% for the next.
Dividend Yield
As stated by Morningstar, Inc., the next dividend payment is on Aug 15, 2023, the estimated forward annual dividend rate is 3 and the estimated forward annual dividend yield is 10.56%.
Moving Average
SELVAAG BOLIG’s value is under its 50-day moving average of kr30.06 and way under its 200-day moving average of kr32.82.
More news about SELVAAG BOLIG.
2. TGS (TGS.OL)
37.4% sales growth and 4.74% return on equity
TGS ASA provides geoscience data products and services to the oil and gas industry worldwide. The company offers geophysical data, including multi-client seismic data; geological data comprising well data products, and interpretive studies and services; and interpretation products and data integration solutions. It also provides imaging services, which include depth and time imaging; marine, land, and ocean bottom nodes; and transition zone, multi component, and 4D time-lapse processing. The company was formerly known as TGS-NOPEC Geophysical Company ASA and changed its name to TGS ASA in June 2021. TGS ASA was founded in 1981 and is headquartered in Oslo, Norway.
Earnings Per Share
As for profitability, TGS has a trailing twelve months EPS of kr4.95.
PE Ratio
TGS has a trailing twelve months price to earnings ratio of 29.41. Meaning, the purchaser of the share is investing kr29.41 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 4.74%.
Revenue Growth
Year-on-year quarterly revenue growth declined by 10.3%, now sitting on 733.84M for the twelve trailing months.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter and the next is 307.6% and 31.3%, respectively.
Dividend Yield
As claimed by Morningstar, Inc., the next dividend payment is on Jul 27, 2023, the estimated forward annual dividend rate is 5.64 and the estimated forward annual dividend yield is 3.85%.
Sales Growth
TGS’s sales growth for the next quarter is 37.4%.
More news about TGS.
3. NAVAMEDIC (NAVA.OL)
17.3% sales growth and 10.19% return on equity
Navamedic ASA, a pharmaceutical company, develops, produces, markets, and sells pharmaceuticals and related products in Northern Europe. The company's product portfolio includes prescription and non-prescription pharmaceuticals, as well as medical nutrition products, medical devices, food supplements, and cosmetics. It offers medical nutrition products for various therapeutic areas, including phenylketonuria, homocystinuria, maple syrup urine disease, tyrosinemia, methylmalonic acidemia/propionic acidemia, glutaric aciduria, isovaleric acidemia, and urea cycle disorders, as well as products for glycogen storage diseases and renal diseases, fat metabolism, malnutrition, and ketogenic diet. In addition, the company provides consumer health products consisting of non-prescription drugs and health care products for pain relief, cough and cold, gastro, obesity, women's health, and others primarily through pharmacies and drugstores; specialty pharmaceutical products in various therapeutic areas comprising dermatology, wound care, urology, and obesity; and branded generics, including cardiology products and antibiotics. It sells, markets, and distributes its products to hospitals, patients, and pharmacies. The company was formerly known as Glucomed AS and changed its name to Navamedic ASA in 2004. Navamedic ASA was incorporated in 2002 and is headquartered in Oslo, Norway.
Earnings Per Share
As for profitability, NAVAMEDIC has a trailing twelve months EPS of kr1.18.
PE Ratio
NAVAMEDIC has a trailing twelve months price to earnings ratio of 33.05. Meaning, the purchaser of the share is investing kr33.05 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.19%.
More news about NAVAMEDIC.
4. SCHLUMBERGER (SLB.PA)
13.1% sales growth and 22.45% return on equity
Schlumberger Limited engages in the provision of technology for the energy industry worldwide. The company operates through four divisions: Digital & Integration, Reservoir Performance, Well Construction, and Production Systems. The company provides field development and hydrocarbon production, carbon management, integration of adjacent energy systems; reservoir interpretation and data processing services for exploration data; and well construction and production improvement services and products. It also offers subsurface geology and fluids evaluation information; open and cased hole services; exploration and production pressure, and flow-rate measurement services; and pressure pumping, well stimulation, and coiled tubing equipment solutions. In addition, the company offers mud logging, directional drilling, measurement-while-drilling, and logging-while-drilling services, as well as engineering support services; supplies drilling fluid systems; designs, manufactures, and markets roller cone and fixed cutter drill bits; bottom-hole-assembly and borehole enlargement technologies; well cementing products and services; well planning, well drilling, engineering, supervision, logistics, procurement, and contracting of third parties, as well as drilling rig management solutions; and drilling equipment and services, as well as land drilling rigs and related services. Further, it provides artificial lift production equipment and optimization services; supplies packers, safety valves, sand control technology, and various intelligent well completions technology and equipment; designs and manufactures valves, chokes, actuators, and surface trees; and OneSubsea an integrated solutions, products, systems, and services, including wellheads, subsea trees, manifolds and flowline connectors, control systems, connectors, and services. The company was formerly known as Socie´te´ de Prospection E´lectrique. Schlumberger Limited was founded in 1926 and is based in Houston, Texas.
Earnings Per Share
As for profitability, SCHLUMBERGER has a trailing twelve months EPS of €2.53.
PE Ratio
SCHLUMBERGER has a trailing twelve months price to earnings ratio of 21.02. Meaning, the purchaser of the share is investing €21.02 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 22.45%.
Volume
Today’s last reported volume for SCHLUMBERGER is 839 which is 91.98% below its average volume of 10468.
More news about SCHLUMBERGER.
5. ITERA (ITERA.OL)
12.4% sales growth and 97.07% return on equity
Itera ASA, together with its subsidiaries, designs, develops, and operates digital solutions for companies and organizations in Norway, Denmark, and Slovakia. It offers data, artificial intelligence and analytics, development and architecture, test and quality assurance solutions, as well as cloud and application services. The company delivers projects and services in the strategy and consulting, customer experience, and technology and cloud transformation areas. Itera ASA was founded in 1989 and is based in Oslo, Norway.
Earnings Per Share
As for profitability, ITERA has a trailing twelve months EPS of kr0.79.
PE Ratio
ITERA has a trailing twelve months price to earnings ratio of 15.25. Meaning, the purchaser of the share is investing kr15.25 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 97.07%.
Moving Average
ITERA’s value is way under its 50-day moving average of kr13.72 and way below its 200-day moving average of kr14.08.
Revenue Growth
Year-on-year quarterly revenue growth grew by 22.7%, now sitting on 831.86M for the twelve trailing months.
More news about ITERA.
